AR020897A1 - VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE - Google Patents

VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE

Info

Publication number: AR020897A1
Authority: AR; Argentina
Prior art keywords: vector; selectly; replicating; vectors; preparation
Prior art date: 1998-10-15

Application number

ARP990105247A

Other languages

English (en)

Original Assignee

Canji Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-15

Filing date

1999-10-15

Publication date

2002-06-05

1999-10-15 Application filed by Canji Inc filed Critical Canji Inc

2002-06-05 Publication of AR020897A1 publication Critical patent/AR020897A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4736—Retinoblastoma protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Virology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ARP990105247A 1998-10-15 1999-10-15 VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE AR020897A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US17268698A	1998-10-15	1998-10-15

Publications (1)

Publication Number	Publication Date
AR020897A1 true AR020897A1 (es)	2002-06-05

Family

ID=22628758

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP990105247A AR020897A1 (es)	1998-10-15	1999-10-15	VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE

Country Status (21)

Country	Link
EP (1)	EP1121441B1 (es)
JP (2)	JP4404490B2 (es)
KR (1)	KR100841815B1 (es)
CN (2)	CN1325647C (es)
AR (1)	AR020897A1 (es)
AT (1)	ATE348169T1 (es)
AU (1)	AU758354B2 (es)
BR (1)	BR9914527A (es)
CA (1)	CA2345900A1 (es)
CZ (1)	CZ301506B6 (es)
DE (1)	DE69934421T2 (es)
ES (1)	ES2279636T3 (es)
HK (1)	HK1040529B (es)
HU (1)	HU226602B1 (es)
IL (2)	IL142337A0 (es)
NO (1)	NO330666B1 (es)
NZ (2)	NZ528283A (es)
PL (1)	PL347898A1 (es)
SK (1)	SK4412001A3 (es)
TW (1)	TWI262948B (es)
WO (1)	WO2000022137A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK4412001A3 (en) *	1998-10-15	2001-12-03	Canji Inc	Selectively replicating viral vectors
KR100492017B1 (ko) *	2002-06-24	2005-05-30	학교법인고려중앙학원	인간 간엽줄기 세포를 이용한 항암치료방법
GB0416487D0 (en)	2004-07-23	2004-08-25	Isis Innovation	Modified virus
ES2385251B1 (es)	2009-05-06	2013-05-06	Fundació Privada Institut D'investigació Biomèdica De Bellvitge	Adenovirus oncolíticos para el tratamiento del cáncer.
EP2825889A4 (en) *	2012-03-14	2015-10-28	Salk Inst For Biological Studi	ADENOVIRAL TUMOR DIAGNOSIS
KR102089121B1 (ko)	2013-03-14	2020-03-13	더 솔크 인스티튜트 포 바이올로지칼 스터디즈	종양살상형 아데노바이러스 조성물
CN106913865A (zh)	2013-04-18	2017-07-04	阿尔莫生物科技股份有限公司	使用白细胞介素‑10治疗疾病和病症的方法
EP4043021A3 (en)	2014-09-24	2022-11-23	Salk Institute for Biological Studies	Oncolytic tumor viruses and methods of use
CA2995120A1 (en)	2015-08-25	2017-03-02	Armo Biosciences, Inc.	Methods of using interleukin-10 for treating diseases and disorders
CA3013639A1 (en)	2016-02-23	2017-08-31	Salk Institute For Biological Studies	Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
JP7054527B2 (ja)	2016-02-23	2022-04-14	ソークインスティテュートフォーバイオロジカルスタディーズ	アデノウイルスの複製動態を測定するための高スループットアッセイ
CN110062630A (zh)	2016-12-12	2019-07-26	萨克生物研究学院	肿瘤靶向合成腺病毒及其用途
KR102609021B1 (ko) *	2017-07-25	2023-12-06	옥스포드 제네틱스 리미티드	아데노바이러스 벡터
KR20250044810A (ko) *	2017-10-10	2025-04-01	난트바이오 인코포레이티드	바이러스 생성 페이로드에 대해 독성이 낮은 변형된 ec7 세포
MX2020010499A (es)	2018-04-09	2020-10-28	Salk Inst For Biological Studi	Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion.
CN115066499A (zh) *	2019-12-30	2022-09-16	格雷菲克斯公司	用于基因转移载体的高效产生的培养系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0931830B1 (en) *	1993-02-16	2001-03-07	Onyx Pharmaceuticals, Inc.	Cytopathic viruses for therapy and phophylaxis of neoplasia
AU4592697A (en) *	1996-09-24	1998-04-17	Dana-Farber Cancer Institute	Method of targeting malignant cells using an e2f responsive promoter
WO1998021228A1 (en) *	1996-11-15	1998-05-22	Canji, Inc.	Tissue specific expression of retinoblastoma protein
AU744725B2 (en) *	1997-03-03	2002-02-28	Cold Genesys, Inc.	Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
SK4412001A3 (en) *	1998-10-15	2001-12-03	Canji Inc	Selectively replicating viral vectors

1999
- 1999-10-14 SK SK441-2001A patent/SK4412001A3/sk unknown
- 1999-10-14 NZ NZ528283A patent/NZ528283A/en unknown
- 1999-10-14 JP JP2000576027A patent/JP4404490B2/ja not_active Expired - Fee Related
- 1999-10-14 DE DE69934421T patent/DE69934421T2/de not_active Expired - Lifetime
- 1999-10-14 BR BR9914527-8A patent/BR9914527A/pt not_active IP Right Cessation
- 1999-10-14 WO PCT/US1999/021452 patent/WO2000022137A2/en not_active Ceased
- 1999-10-14 NZ NZ510805A patent/NZ510805A/en not_active IP Right Cessation
- 1999-10-14 CN CNB998143618A patent/CN1325647C/zh not_active Expired - Fee Related
- 1999-10-14 AU AU63915/99A patent/AU758354B2/en not_active Ceased
- 1999-10-14 HU HU0104107A patent/HU226602B1/hu unknown
- 1999-10-14 PL PL99347898A patent/PL347898A1/xx not_active Application Discontinuation
- 1999-10-14 TW TW088117803A patent/TWI262948B/zh not_active IP Right Cessation
- 1999-10-14 AT AT99951481T patent/ATE348169T1/de not_active IP Right Cessation
- 1999-10-14 ES ES99951481T patent/ES2279636T3/es not_active Expired - Lifetime
- 1999-10-14 IL IL14233799A patent/IL142337A0/xx unknown
- 1999-10-14 CA CA002345900A patent/CA2345900A1/en not_active Abandoned
- 1999-10-14 HK HK02101003.1A patent/HK1040529B/en not_active IP Right Cessation
- 1999-10-14 KR KR1020017004690A patent/KR100841815B1/ko not_active Expired - Fee Related
- 1999-10-14 EP EP99951481A patent/EP1121441B1/en not_active Expired - Lifetime
- 1999-10-14 CZ CZ20011129A patent/CZ301506B6/cs not_active IP Right Cessation
- 1999-10-14 CN CN2007101040311A patent/CN101092636B/zh not_active Expired - Fee Related
- 1999-10-15 AR ARP990105247A patent/AR020897A1/es active IP Right Grant
2001
- 2001-04-01 IL IL142337A patent/IL142337A/en not_active IP Right Cessation
- 2001-04-10 NO NO20011843A patent/NO330666B1/no not_active IP Right Cessation
2009
- 2009-08-04 JP JP2009181782A patent/JP2009254385A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
TWI262948B (en)	2006-10-01
CN101092636B (zh)	2012-08-08
KR100841815B1 (ko)	2008-06-26
BR9914527A (pt)	2001-06-26
NZ510805A (en)	2003-12-19
HUP0104107A3 (en)	2003-09-29
DE69934421D1 (de)	2007-01-25
SK4412001A3 (en)	2001-12-03
HK1040529A1 (en)	2002-06-14
ATE348169T1 (de)	2007-01-15
AU758354B2 (en)	2003-03-20
JP2002541761A (ja)	2002-12-10
CA2345900A1 (en)	2000-04-20
HUP0104107A2 (hu)	2002-03-28
CN101092636A (zh)	2007-12-26
NO20011843D0 (no)	2001-04-10
JP4404490B2 (ja)	2010-01-27
IL142337A (en)	2009-05-04
ES2279636T3 (es)	2007-08-16
AU6391599A (en)	2000-05-01
NO20011843L (no)	2001-06-14
NO330666B1 (no)	2011-06-06
KR20020013472A (ko)	2002-02-20
CN1325647C (zh)	2007-07-11
CN1330715A (zh)	2002-01-09
DE69934421T2 (de)	2007-10-11
EP1121441A2 (en)	2001-08-08
IL142337A0 (en)	2002-03-10
JP2009254385A (ja)	2009-11-05
CZ20011129A3 (cs)	2002-01-16
EP1121441B1 (en)	2006-12-13
NZ528283A (en)	2005-05-27
CZ301506B6 (cs)	2010-03-31
WO2000022137A3 (en)	2000-08-03
HU226602B1 (en)	2009-04-28
WO2000022137A2 (en)	2000-04-20
HK1040529B (en)	2007-02-09
PL347898A1 (en)	2002-04-22

Publication	Publication Date	Title
AR020897A1 (es)	2002-06-05	VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE
HUP0004853A3 (en)	2001-12-28	Hepatitis c inhibitor peptides, process for preparation thereof, pharmaceutical compositions comprising thereof, their use and their intermediates
HUP0104548A3 (en)	2002-12-28	Hepatitis c inhibitor peptides, process for their preparation, pharmaceutical compositions conprising thereof and their use
EP1023050A4 (en)	2006-08-30	NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THEIR PREPARATION AND USE
HUP0104574A3 (en)	2002-09-30	Analogues of glp-1, pharmaceutical compositions comprising thereof and their use
DK1275387T3 (da)	2006-08-28	Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
CZ297999A3 (cs)	1999-12-15	Arylsulfonamidy a jejich analogy, způsob jejich výroby, meziprodukty pro jejich výrobu, farmaceutické prostředky tyto látky obsahující a jejich použití
EE200000380A (et)	2001-12-17	11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks
HUP0004400A3 (en)	2002-10-28	Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
BR9807814B1 (pt)	2009-01-13	composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
DK1066049T3 (da)	2003-09-29	Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse
FR2811552B1 (fr)	2002-12-27	Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
HUP0004040A3 (en)	2001-08-28	Pleuromutilin derivatives as antimicrobials, process for their preparation, pharmaceutical compositions, comprising thereof and their use
MX20055A (es)	1993-10-01	Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion.
BR9808422B1 (pt)	2010-08-24	composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9603429A (pt)	1998-05-12	Derivado de 11-(fenila substituída) estra-4,9-dieno processo de preparação do mesmo composição farmacêutica e uso deste derivado
IL98845A0 (en)	1992-07-15	Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
GB0029936D0 (en)	2001-01-24	A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation
HUP0202233A3 (en)	2004-12-28	Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
GB2327190B (en)	2002-04-17	Process for the preparation of depilatory compositions and their use
BR9801150A (pt)	2000-03-21	Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
AR028588A1 (es)	2003-05-14	Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y uso
ZA97277B (en)	1997-07-16	Novel benzoylguanidine derivatives processes for preparing them and their use in the preparation of pharmaceutical compositions
IL113484A0 (en)	1995-07-31	Viral proteins pharmaceutical compositions containing them their preparation and use
NO951418D0 (no)	1995-04-11	Peptidderivater, deres fremstilling og anvendelse som terapeutika

Legal Events

Date	Code	Title	Description
2008-02-29	FG	Grant, registration